Evoke Pharma, Inc. (EVOK)

NASDAQ: EVOK · IEX Real-Time Price · USD
-0.09 (-5.14%)
At close: May 31, 2023, 2:24 PM
+0.01 (0.60%)
After-hours: May 31, 2023, 4:45 PM EDT

Company Description

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females.

The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers.

Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Evoke Pharma, Inc.
Evoke Pharma logo
Country United States
Founded 2007
IPO Date Sep 25, 2013
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 4
CEO David A. Gonyer R.Ph.

Contact Details

420 Stevens Avenue, Suite 370
Solana Beach, California 92075
United States
Phone 858-345-1494
Website evokepharma.com

Stock Details

Ticker Symbol EVOK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001403708
CUSIP Number 30049G104
ISIN Number US30049G1040
Employer ID 20-8447886
SIC Code 2834

Key Executives

Name Position
David A. Gonyer Co-Founder, Chief Executive Officer, President and Director
Matthew J. D'Onofrio Co-Founder, Chief Business Officer, Executive Vice President, Treasurer and Secretary
Dr. Marilyn R. Carlson Chief Medical Officer
Christopher Quesenberry Chief Commercial Officer - Gimoti (TM)

Latest SEC Filings

Date Type Title
May 26, 2023 8-K Current Report
May 18, 2023 CT ORDER Filing
May 15, 2023 8-K Current Report
May 15, 2023 10-Q Quarterly Report
May 11, 2023 8-K Current Report
May 9, 2023 8-K Current Report
May 1, 2023 8-K Current Report
Apr 20, 2023 8-K Current Report
Apr 6, 2023 8-K Current Report
Mar 29, 2023 DEF 14A Other definitive proxy statements